Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

PIDILITIND - Investment Analysis: Buy Signal or Bull Trap?

Last Updated Time : 20 Dec 25, 07:10 am

Back to Investment List

Investment Rating: 3.9

Stock Code PIDILITIND Market Cap 1,48,759 Cr. Current Price 1,462 ₹ High / Low 1,575 ₹
Stock P/E 66.7 Book Value 92.8 ₹ Dividend Yield 0.69 % ROCE 30.5 %
ROE 23.2 % Face Value 1.00 ₹ DMA 50 1,479 ₹ DMA 200 1,491 ₹
Chg in FII Hold -0.05 % Chg in DII Hold 0.00 % PAT Qtr 586 Cr. PAT Prev Qtr 650 Cr.
RSI 42.1 MACD -5.13 Volume 2,68,718 Avg Vol 1Wk 3,42,910
Low price 1,310 ₹ High price 1,575 ₹ PEG Ratio 3.27 Debt to equity 0.03
52w Index 57.2 % Qtr Profit Var 8.10 % EPS 21.8 ₹ Industry PE 26.6

📊 Analysis: PIDILITIND demonstrates strong fundamentals with ROE (23.2%) and ROCE (30.5%) reflecting excellent capital efficiency. Debt-to-equity ratio (0.03) indicates a virtually debt-free balance sheet, adding financial stability. Dividend yield (0.69%) provides minor income support. However, valuations are stretched with P/E (66.7) vs industry PE (26.6) and PEG ratio (3.27), suggesting overvaluation relative to growth. Current price (₹1,462) is slightly below DMA 50 (₹1,479) and DMA 200 (₹1,491), showing weak technical trend. RSI (42.1) and MACD (-5.13) indicate cautious momentum. Quarterly PAT declined from ₹650 Cr. to ₹586 Cr., though YoY growth (+8.10%) remains positive. Long-term compounding potential exists due to strong efficiency and brand leadership, but entry should be cautious given valuations.

💰 Ideal Entry Zone: ₹1,350 – ₹1,450 (near support levels and valuation comfort). This provides margin of safety for long-term investors.

📈 Exit / Holding Strategy: For existing holders, maintain positions for 3–5 years given strong ROE/ROCE and debt-free status. Consider partial profit booking near ₹1,550–₹1,575 resistance. Exit only if price sustains below ₹1,310 with weakening fundamentals. Long-term holding is favorable for compounding growth, though valuations may cap upside.


Positive

Limitation

Company Negative News

Company Positive News

Industry

Conclusion

🔑 PIDILITIND is a fundamentally strong company with excellent efficiency and debt-free status, but valuations are stretched. Entry near ₹1,350–₹1,450 offers margin of safety. Long-term holding (3–5 years) is favorable for compounding growth, with partial profit booking near resistance levels. Conservative investors should wait for valuation comfort before committing to extended positions.

Would you like me to prepare a peer benchmarking overlay comparing PIDILITIND with other specialty chemical and adhesive peers (like Asian Paints, Berger Paints, and Astral) to highlight stronger compounding opportunities?

Back to Investment List

NIFTY 50 - Today Top Investment Picks Stock Picks

NEXT 50 - Today Top Investment Picks Stock Picks

MIDCAP - Today Top Investment Picks Stock Picks

SMALLCAP - Today Top Investment Picks Stock Picks